Vimarsana
Biggest News Aggregation in the World

Zycov D News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zycov D. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zycov D Today - Breaking & Trending Today

National News: Govt will decide on Covid vaccination of children, adolescents on 'scientific rationale', supply situation: V K Paul | India News – Rashtra News - Vimarsana News

National News: Govt will decide on Covid vaccination of children, adolescents on 'scientific rationale', supply situation: V K Paul | India News – Rashtra News

Published: April 24, 2024

Govt will decide on Covid vaccination of children, adolescents on 'scientific rationale', supply situation: V K Paul | India News - Rashtra News : Rashtra News #Govt #decide #Covid #vaccination #children #adolescents #scientific #rationale #supply #situation #Paul #India #News #Times #India NEW DELHI: The government will take a final decision on vaccinating children and adolescents

Source: rashtranews.com
Related Topics:
Zydus CadilaNational Technical Advisory Group On ImmunisationUnion Health MinistryCovid TaskIndia NewsRashtra NewsCovid Task ForceEmergency Use AuthorisationBharat BiotechDrugs Controller GeneralNational Technical Advisory GroupNews SourceBreaking NewsGoogle NewsIndia News TodayToday NewsZycov D
Meet Pankaj Patel, India's pharma magnate with Rs 42,600 crore net worth, owns Rs 52,400 crore business empire - Vimarsana News

Meet Pankaj Patel, India's pharma magnate with Rs 42,600 crore net worth, owns Rs 52,400 crore business empire

Published: April 25, 2023

Pankaj Patel's company, Zydus Lifesciences, also manufactures the Covid-19 vaccine, ZyCoV-D.

Source: dnaindia.com
Related Topics:
Priti PatelZydus LifesciencesPankaj Ramanbhai PatelSharvil PatelRamanbhai PatelPankaj PatelPranavd PatelCadila Healthcare LtdGujarat UniversityCadila HealthcarePankaj RamanbhaiZydus Lifesciences LimitedIndravadan ModiBusiness NewsPankaj PatelHo Is Pankaj PatelHarma Magnate Pankaj PatelAnkaj Patel NewsAnkaj Patel Net WorthAnkaj Patel Business EmpireCovid 19 VaccineZycov DZydus LifesciencesZydus Vaccine
Vaccination rates have gone up amid COVID-19 scare in India: Jyotiraditya Scindia - Vimarsana News

Vaccination rates have gone up amid COVID-19 scare in India: Jyotiraditya Scindia

Published: December 23, 2022

Scindia was addressing a presser on the Union Health Ministry’s initiatives to tackle COVID-19. 

Source: businesstoday.in
Related Topics:
Zydus Cadila ZycoJyotiraditya ScindiaMansukh MandaviyaUnion HealthUnion Health MinistryUnion Civil AviationNation One HealthSerum Institute Of IndiaUnion MinisterBharat BiotechSerum InstituteZydus CadilaOne Nation HealthHealth Minister Dr Mansukh MandaviyaNew Covid Variant ReachesCovid 19 ScareNdia Covid 19 ScareCovid 19 Scare In IndiaCovid 19 VaccineCovid 19 Vaccine DosesCovid 19 Vaccine Doses In IndiaIndia Covid 19 Vaccine DosesIndia Covid 19 VaccineOvid 19 Vaccination Rates In IndiaJyotiraditya Scindia
WHO 'strongly recommends' Pfizer's Covid-19 pill for at-risk patients: Report | World News - Vimarsana News

WHO 'strongly recommends' Pfizer's Covid-19 pill for at-risk patients: Report | World News

Published: April 22, 2022

The WHO experts said that US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid-19, according to AFP.

Source: india.com
Related Topics:
South AfricaCity OfUnited KingdomAmita GuptaJohns HopkinsWorld Health OrganizationExpert CommitteeDivision Of Infectious DiseaseInfectious DiseaseJohns Hopkins University SchoolSubject Expert CommitteeBharat BiotechEmergency Use ListingCovid 19 PillJohns HopkinsZycov D
Biological E COVID shot gets India emergency approval for 12-18 age group - Vimarsana News

Biological E COVID shot gets India emergency approval for 12-18 age group

Published: February 21, 2022

Biological E COVID shot gets India emergency approval for 12-18 age group

Source: bdnews24.com
Related Topics:
Mansukh MandaviyaSerum Institute Of IndiaZydus CadilaBharat BiotechSerum InstituteBiologicale Covid Shot2 18 AgeCovid 19Serum Institute Of IndiaYdus Cadilas Dna ShotZycov DBharat Biotechs Covaxin